Edition:
India

Forward Pharma A/S (FWP.OQ)

FWP.OQ on NASDAQ Stock Exchange Global Select Market

4.19USD
8 Dec 2017
Change (% chg)

-- (--)
Prev Close
$4.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,110
52-wk High
$32.70
52-wk Low
$3.99

Latest Key Developments (Source: Significant Developments)

Forward Pharma Files Further Written Submissions In European Opposition Proceeding For EP2801355 Patent
Thursday, 30 Nov 2017 

Nov 29 (Reuters) - Forward Pharma A/S ::FORWARD PHARMA FILES FURTHER WRITTEN SUBMISSIONS IN THE EUROPEAN OPPOSITION PROCEEDING FOR THE EP2801355 PATENT IN PREPARATION FOR THE ORAL HEARING IN JANUARY 2018.FORWARD PHARMA A/S - FILING OF FURTHER WRITTEN SUBMISSIONS IN EUROPEAN OPPOSITION PROCEEDING FOR EP2801355 PATENT WITH EPO.FORWARD PHARMA A/S - FILING WILL BECOME PUBLICLY AVAILABLE VIA EUROPEAN PATENT REGISTER.FORWARD PHARMA A/S - AN ORAL HEARING IS CURRENTLY SCHEDULED FOR JANUARY 29-30, 2018.FORWARD PHARMA A/S - POSSIBILITY TO APPEAL DECISION OF OPPOSITION DIVISION TO TECHNICAL BOARD OF APPEAL.  Full Article

Forward Pharma announces completion of corporate restructuring plan
Thursday, 23 Nov 2017 

Nov 22 (Reuters) - Forward Pharma A/S :Forward Pharma announces completion of corporate restructuring plan.  Full Article

Forward Pharma receives $1.25 bln pursuant to settlement and license agreement with Biogen
Thursday, 9 Feb 2017 

Forward Pharma A/S - : Forward Pharma received US$ 1.25 bln pursuant to settlement and license agreement with Biogen .Forward Pharma A/S - received non-refundable cash fee of US$1.25 billion in connection with settlement and license agreement with two units of Biogen.  Full Article

Forward Pharma reports qtrly adj loss of per share $0.27
Thursday, 1 Sep 2016 

Forward Pharma A/S - : Forward pharma reports second quarter 2016 financial and operational results . Q2 loss per share $0.32 . Q2 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S . Qtrly non-GAAP loss per share $0.27 ."continue to anticipate that our rate of research and development spending will increase in future quarters".  Full Article

Forward pharma A/S Q1 earnings per share $0.12
Friday, 3 Jun 2016 

Forward Pharma A/S : Q1 earnings per share $0.12 . On a non-gaap basis, Q1 net loss for 2016 would have been $9.0 million, or $0.19 per basic share . Forward Pharma reports first quarter 2016 financial and operational results .Q1 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Forward Pharma Files Further Written Submissions In European Opposition Proceeding For EP2801355 Patent

* FORWARD PHARMA FILES FURTHER WRITTEN SUBMISSIONS IN THE EUROPEAN OPPOSITION PROCEEDING FOR THE EP2801355 PATENT IN PREPARATION FOR THE ORAL HEARING IN JANUARY 2018